https://cienciadigital.org/revistacienciadigital2/index.php/AnatomiaDigital/issue/feed Anatomía Digital 2024-11-30T12:11:13+00:00 Dr.C. Efraín Velasteguí López PhD. luisefrainvelastegui@cienciadigital.org Open Journal Systems <div id="inicio"> <p>The <strong>Anatomía Digital</strong> journal promotes research in medical science and health in general. It is published quarterly, uninterruptedly, and publishes scientific manuscripts and communications on clinical, educational and scientific aspects.</p> </div> <div class="additional_content"> <div class="container" style="width: 100%;"> <div class="row2"> <div class="aimcolumn aimleft"><img style="width: 140%;" src="/revistacienciadigital2/public/site/images/diego91/find-a-provider.png"></div> <div class="aimcolumn aimright"> <div class="journal-description"> <p>The<strong> Anatomía Digital</strong> journal promotes research in medical science and health in general. It is published quarterly, uninterruptedly, and publishes scientific manuscripts and communications on clinical, educational and scientific aspects.</p> </div> <ul> <li class="show"><strong>Editor in Chief:</strong>DrC. Efraín Velasteguí López PhD</li> <li class="show"><strong>ISSN (online)</strong>: 2697-3391</li> <li class="show"><strong>Frequency:</strong>Quarterly</li> <li class="show"><strong>SJIF Journal Impact Value:</strong>[<a href="http://sjifactor.com/passport.php?id=22202">SJIF 2020 = 5.711</a>]</li> </ul> <div>&nbsp;</div> <div><a href="https://scholar.google.es/scholar?hl=es&amp;as_sdt=0%2C5&amp;q=2697-3391&amp;btnG=" target="_blank" rel="noopener"><img class="zoom2" src="/revistacienciadigital2/public/site/images/diego91/google-scholar-png.png" width="130" height="37"></a> <a href="https://www.base-search.net/Search/Results?type=all&amp;lookfor=Anatomia+Digital&amp;ling=1&amp;oaboost=1&amp;name=&amp;thes=&amp;refid=dcreses&amp;newsearch=1" target="_blank" rel="noopener"><img class="zoom2" src="/revistacienciadigital2/public/site/images/diego91/base_logo_kl.png" width="101" height="39"></a> &nbsp; &nbsp; <a href="https://search.crossref.org/?q=Anatomia+Digital&amp;from_ui=yes" target="_blank" rel="noopener"><img class="zoom2" src="/revistacienciadigital2/public/site/images/diego91/crossref.png" width="95" height="43"></a></div> </div> </div> </div> <section id="what-we-do"> <div class="container-fluid2"> <h1>Why publish with us?</h1> <div class="row2 mt-5"> <div class="col"> <div class="card"> <div class="card-block block-1"> <h3>Open Access</h3> <p>Anatomía Digital is a strong supporter of open access (OA). All research articles published in Anatomía Digital are fully open access.</p> <a class="read-more" title="Read more" href="https://cienciadigital.org/revistacienciadigital2/index.php/AnatomiaDigital/infolegal" target="_blank" rel="noopener">Read more<em class="fa fa-angle-double-right ml-2"><!-- icon --></em></a></div> </div> </div> <div class="col"> <div class="card"> <div class="card-block block-2"> <h3>Referee</h3> <p>Peer review process: Committed to serving the scientific community. Digital Anatomy uses a double-blind peer review process</p> <a class="read-more" title="Read more" href="https://cienciadigital.org/revistacienciadigital2/index.php/AnatomiaDigital/about/submissions" target="_blank" rel="noopener">Read more<em class="fa fa-angle-double-right ml-2"><!-- icon --></em></a></div> </div> </div> <div class="w-100">&nbsp;</div> <div class="col"> <div class="card"> <div class="card-block block-3"> <h3>Indexed</h3> <p>The journal is indexed and summarized in Latindex Catalog 2.0, Latinrev, Google Scholar. Periodical publications.</p> <a class="read-more" title="Read more" href="https://cienciadigital.org/revistacienciadigital2/index.php/AnatomiaDigital/indexa" target="_blank" rel="noopener">Read more<em class="fa fa-angle-double-right ml-2"><!-- icon --></em></a></div> </div> </div> <div class="col"> <div class="card"> <div class="card-block block-4"> <h3>No Payment</h3> <p>Digital Anatomy accepts original research articles and does not charge a publication fee.</p> <a class="read-more" title="Read more" href="https://cienciadigital.org/revistacienciadigital2/index.php/AnatomiaDigital/about/submissions" target="_blank" rel="noopener">Read more<em class="fa fa-angle-double-right ml-2"><!-- icon --></em></a></div> </div> </div> </div> </div> </section> </div> https://cienciadigital.org/revistacienciadigital2/index.php/AnatomiaDigital/article/view/3245 Fournier's gangrene. Etiology, diagnosis, and treatment 2024-11-28T14:27:20+00:00 Jorge Luis Zambrano Sánchez jzambrano0414@utm.edu.ec Andrea Stefany Ramos Tuarez aramos@utm.edu.ec Virginia Durán Castro virginiaduran.17@gmail.com Richard Franklin Avellan Zambrano sanpanchouciasf@gmail.com Andrea Isabel Quiroga Sabando isa20011939@gmail.com Melissa Moreira M. melimoreira.med@gmail.com <p><strong>Background: </strong>Fournier's Gangrene (FG) is a severe necrotizing infection of soft tissues, primarily affecting the perineum, genitals, and lower abdomen. Although rare, its high mortality and rapid progression demand a comprehensive understanding of its management. <strong>Objective:</strong> This review aims to evaluate the clinical, diagnostic, and therapeutic aspects of Fournier's gangrene, providing an updated overview of its management and outcomes. <strong>Methodology:</strong> A comprehensive literature review was conducted, focusing on recent and relevant studies on Fournier's gangrene. Articles addressing clinical management, diagnosis, therapeutic interventions, and associated comorbidities were evaluated. <strong>Results:</strong> The reviewed studies indicate that Fournier's gangrene is often associated with comorbidities such as diabetes mellitus and urological diseases. Early detection and prompt surgical intervention are crucial for improving prognosis. Standard treatment involves aggressive surgical debridement, broad-spectrum antibiotic therapy, and management of underlying conditions. Despite advancements in treatment strategies, mortality rates remain high. <strong>Conclusion:</strong> Fournier's gangrene is a medical emergency that requires rapid intervention and a multidisciplinary approach. The combination of early debridement, appropriate antibiotic therapy, and management of comorbidities is essential for improving outcomes and reducing mortality. Ongoing research is needed to optimize treatment strategies and improve the quality of life for affected patients. <strong>General area of ​​study:</strong> medicine. <strong>Specific study area:</strong> general surgery and coloproctology. <strong>Type of study:</strong> narrative review.</p> 2024-11-28T14:17:42+00:00 Copyright (c) 2024 Anatomía Digital https://cienciadigital.org/revistacienciadigital2/index.php/AnatomiaDigital/article/view/3247 Prevalence of beta-lactamases in urine cultures of outpatients at the Vicente Corral Moscoso Hospital, period 2019 – 2022 2024-11-30T12:11:13+00:00 María Fernanda Guamán Sánchez fernanda.guaman@ucuenca.du.ec Paola Ibeth Borja González pao.bor2515@gmail.com Edwin Ismael Gómez Muicela win25ismael@hotmail.com Bertha Susana Rojas Lupercio bertha.rojas@ucacue.edu.ec <p><strong>Introduction:</strong> In recent years, a significant increase in the prevalence of resistant uropathies has been observed, with extended-spectrum beta-lactamase-producing bacteria being one of the most important groups, due to their mechanism of hydrolyzing beta-lactam antibiotics. <strong>Objective: </strong>To determine the prevalence of beta-lactamases in urine cultures of outpatients at the <u>Vicente Corral Moscoso Hospital</u>, period 2019 – 2022. <strong>Methodology: </strong>The methodology is quantitative research, with a cross-sectional, observational, descriptive-explanatory study. It was conducted at the <u>Vicente Corral Moscoso Hospital</u>, the study universe constitutes all the urine cultures of patients seen in the outpatient clinic in the period 2019 to 2022, with a total of 903 patients, the variables to be studied are: Age, sex, isolated microorganism, resistance to beta-lactam antibiotics, resistance to other antibiotics. The SPSS statistical package was used for data analysis.<strong> Results: </strong>the population was female with 80.3 %. Among the main bacteria producing extended-spectrum beta-lactamase in urine cultures from outpatients, <em>Escherichia coli</em> was identified as the most common bacterium in urine cultures with a total of 89.8%; however, only 21.0% reported positive for beta-lactamase, as well as 7.7% of<em> Klebsiella oxytoca</em> and 58.1% of <em>Klebsiella pneumoniae. </em><strong>Conclusion: </strong>the prevalence and patterns of resistance and sensitivity of bacteria producing extended-spectrum beta-lactamases are comparable with both local and international epidemiology.</p> 2024-11-30T12:04:04+00:00 Copyright (c) 2024 Anatomía Digital